Followers | 3820 |
Posts | 238892 |
Boards Moderated | 0 |
Alias Born | 07/30/2007 |
Monday, August 09, 2021 10:22:07 PM
Recent BYSI News
- BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer • GlobeNewswire Inc. • 03/25/2024 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/26/2024 01:01:19 PM
- BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price and Periodic Filing Requirements • GlobeNewswire Inc. • 02/26/2024 01:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:30:59 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/02/2024 09:30:32 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/16/2024 09:30:13 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/10/2024 08:00:38 PM
- BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K • GlobeNewswire Inc. • 01/10/2024 08:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/18/2023 09:31:23 PM
- BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements • GlobeNewswire Inc. • 12/18/2023 09:30:00 PM
- BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity of Plinabulin Inducing Dendritic Cell Maturation and Re-sensitization in Immunotherapy Refractory Tumors when Combined with Radiation and PD-1/PD-L1 Inhibitors • GlobeNewswire Inc. • 11/07/2023 12:00:00 PM
- BeyondSpring and Professor K. Eisenmann of the University of Toledo College of Medicine Present Poster Highlighting Plinabulin’s Anti-cancer Efficacy in Primary and Recurrent Glioblastoma Patient Derived Invasive Neurosphere Models • GlobeNewswire Inc. • 10/31/2023 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/30/2023 12:05:19 PM
- BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 10/30/2023 12:00:00 PM
- SEED Therapeutics Discloses Novel Molecular Glue IND Candidate for Cancer at “Targeted Protein Degradation Think Tank” Symposium • GlobeNewswire Inc. • 10/26/2023 12:30:00 PM
- SEED Therapeutics, a BeyondSpring Subsidiary, Appoints Mr. Ko-Yung Tung to the Board of Directors • GlobeNewswire Inc. • 10/23/2023 11:45:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/04/2023 08:00:38 PM
- BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements • GlobeNewswire Inc. • 10/04/2023 07:55:00 PM
- BeyondSpring and Leading Cancer Center to Present Poster at SITC’s 38th Annual Meeting • GlobeNewswire Inc. • 09/27/2023 02:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/20/2023 09:20:19 PM
- BeyondSpring to Participate in the R.W. Baird’s 2023 Global Healthcare Conference • GlobeNewswire Inc. • 09/07/2023 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/14/2023 08:30:54 PM
- SEED Therapeutics, BeyondSpring Subsidiary, Appoints Jackson Tai to Board of Directors • GlobeNewswire Inc. • 06/20/2023 12:00:00 PM
- BeyondSpring and Leading Cancer Center Present Poster Highlighting Plinabulin’s Ability to Reduce Infectious Neutropenic Fever for Multiple Myeloma Patients Undergoing AHCT • GlobeNewswire Inc. • 06/07/2023 12:00:00 PM
- BeyondSpring and Leading Cancer Center to Present Poster at 2023 ASCO Annual Meeting • GlobeNewswire Inc. • 05/18/2023 12:30:00 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM